It took the FDA less than three months to evaluate and approve the application for Prostent mobile service. In a mobile configuration, the Prostatron is installed in a trailer and transported from one hospital to the other.
Hospitals can contract to have the services available to their patients on a rotating basis.
This set up allows hospitals to provide the latest medical therapy, cost-effectively. In many instances, it provides a trial run to insure that they have the patient populations prior to committing to an actual purchase of the machine. BPH affects 9 million men over the age of 50 throughout the United States alone. The one-hour outpatient procedure requires only local anesthesia, and has virtually none of the risks or financial cost of surgical procedures. Patients can resume normal activities immediately following treatment.